UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.â„¢ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
RENO, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. Â (Nasdaq: CNXU) ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, today announced the launch...
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
Public listing marks key milestone as Conexeu advances proprietary CXU(TM) platform and vision for regenerative medicine focused on biological restorationReno, Nevada--(Newsfile Corp. - May 21, 2026) -...